Health & Biotech
Medlab is an Australian biotechnology company, focused on the delivery of medicinal solutions and hope for patients with unmet needs. Medlab is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®. With NanoCelle® the company has launched and is investigating a broad range of prescription and non-prescription solutions for patient needs across a variety of therapeutic areas including: pain management, mental health, gut health, diabetes, and allergies.
Medlab specialise in solutions that can provide improved bioavailability leading to better outcomes, fewer side effects and improved quality of life through agile innovative research and expertise in both large and small molecule delivery, throughout the entire supply chain process, from concept to the manufactured end product.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Explainers
ASX Cannabis Stocks Guide 2022/23: Here’s everything you need to know
Health & Biotech
Clinical Trials 101: The critical review process and getting drugs to market
Health & Biotech
Clinical Trials 101: How to know your placebos from blinded studies
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
Weed Week: Ice-T plans to open dispensary and Snoop Dogg’s venture capital firm backs weed snacks
Health & Biotech
Medlab’s NRGBiotic depression patent formally accepted by European watchdog
Health & Biotech
Medlab’s NanoCelle tech hits a bullseye for future drug-delivery
News
ASX Quarterlies: Tech powers ahead in strong finish to reporting week
Stockhead TV
V-Con: Small Cap Showcase – Companies set to perform and best bargains amidst turbulent market conditions
Health & Biotech
Weed Week: Cannabis lounges in Las Vegas and Cann’s Mildura cannabis facility gets GMP licence
Health & Biotech
Medlab Clinical heads for Nasdaq listing and land of opportunity
Health & Biotech
Study finds Medlab on right track to advance drug delivery for better patient outcomes
Health & Biotech
Medlab teams up with Malaysian consumer health giant to crack open an eager Asian market
News
Market highlights and 5 ASX small caps to watch on Thursday
Health & Biotech
Could Aussie cannabinoid companies help solve a global opioid crisis?
Health & Biotech
Medlab wants to get right up COVID’s nose, as nasal vaccine program gathers steam
Health & Biotech